daptomycin in sodium chloride

Generic: daptomycin in sodium chloride

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name daptomycin in sodium chloride
Generic Name daptomycin in sodium chloride
Labeler baxter healthcare corporation
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

daptomycin 500 mg/50mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 0338-0714
Product ID 0338-0714_7b6f75eb-02dd-4906-9ee1-4c658a5e36b3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA213645
Listing Expiration 2027-12-31
Marketing Start 2022-01-25

Pharmacologic Class

Established (EPC)
lipopeptide antibacterial [epc]
Chemical Structure
lipopeptides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03380714
Hyphenated Format 0338-0714

Supplemental Identifiers

RxCUI
2632127 2632130 2632132 2632133
UNII
NWQ5N31VKK
NUI
N0000175509 M0519359

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name daptomycin in sodium chloride (source: ndc)
Generic Name daptomycin in sodium chloride (source: ndc)
Application Number NDA213645 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 500 mg/50mL
source: ndc
Packaging
  • 24 BAG in 1 CARTON (0338-0714-24) / 50 mL in 1 BAG
source: ndc

Packages (1)

Ingredients (1)

daptomycin (500 mg/50mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7b6f75eb-02dd-4906-9ee1-4c658a5e36b3", "openfda": {"nui": ["N0000175509", "M0519359"], "unii": ["NWQ5N31VKK"], "rxcui": ["2632127", "2632130", "2632132", "2632133"], "spl_set_id": ["7ed4d986-2aa9-43cd-9a8a-fbd11cb5ecef"], "pharm_class_cs": ["Lipopeptides [CS]"], "pharm_class_epc": ["Lipopeptide Antibacterial [EPC]"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 BAG in 1 CARTON (0338-0714-24)  / 50 mL in 1 BAG", "package_ndc": "0338-0714-24", "marketing_start_date": "20230227"}], "brand_name": "Daptomycin in Sodium Chloride", "product_id": "0338-0714_7b6f75eb-02dd-4906-9ee1-4c658a5e36b3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Lipopeptide Antibacterial [EPC]", "Lipopeptides [CS]"], "product_ndc": "0338-0714", "generic_name": "Daptomycin in Sodium Chloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Daptomycin in Sodium Chloride", "active_ingredients": [{"name": "DAPTOMYCIN", "strength": "500 mg/50mL"}], "application_number": "NDA213645", "marketing_category": "NDA", "marketing_start_date": "20220125", "listing_expiration_date": "20271231"}